Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 8, 2022Virtual Press Office and PR Newswire: General Trade show news
From September 2 to 6, the five-day IFA 2022 was being held at Berlin Convention and Exhibition Center, Germany. Laifen participated in it together with more than 2000 other companies. As the...
-
Sep 8, 2022Virtual Press Office and PR Newswire: General Trade show news
EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological tumors, announced today that its Chief Business...
-
Sep 8, 2022Virtual Press Office and PR Newswire: General Trade show news
Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today announced that final data from its phase II study of paxalisib in patients with newly...
-
Sep 8, 2022Virtual Press Office and PR Newswire: General Trade show news
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease,...
-
Sep 8, 2022Virtual Press Office and PR Newswire: General Trade show news
Corporate Presentation to Highlight Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 8, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...